Overview and Scope
Transfection reagents refer to substances or kits used to introduce foreign genetic material, such as DNA or RNA, into cells. These reagents facilitate the delivery of nucleic acids into cells, allowing researchers to study gene expression, manipulate gene function, or produce recombinant proteins.
Sizing and Forecast
The transfection reagents and equipment market size has grown rapidly in recent years. It will grow from $1.46 billion in 2023 to $1.62 billion in 2024 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to biomedical research demand, pharmaceutical development, rise in biotechnology applications, academic and research institutions, genetic engineering advancements..
The transfection reagents and equipment market size is expected to see rapid growth in the next few years. It will grow to $2.43 billion in 2028 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to gene therapy advancements, increasing bioproduction needs, emerging cell-based therapies, r&d in personalized medicine, global collaborations.. Major trends in the forecast period include focus on primary cell transfection, shift towards electroporation techniques, integration of nanotechnology in transfection, increasing demand for animal-free transfection reagents, automation and high-throughput transfection systems..
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/transfection-reagents-and-equipment-global-market-report
Segmentation & Regional Insights
The transfection reagents and equipment market covered in this report is segmented –
1) By Products: Instruments, Reagent And Kits
2) By Types Of Molecule: Plasmid DNA, DNA Oligonucleotides, Small Interfering RNA (SiRNA), Proteins, Ribonucleoprotein Complexes (RNPs), Other Molecules
3) By Organism: Bacteria, Mammalian Cells, Fungi, Plants, Virus
4) By End User: Biopharma, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs) And Contract Development And Manufacturing Organizations (CDMOs), Academia, Hospitals, Clinical Labs, Other End Users
North America was the largest region in the transfection reagents and equipment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection reagents and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=10780&type=smp
Major Driver Impacting Market Growth
The rising number of cancer patients worldwide is expected to propel the growth of the transfection reagents and equipment market going forward. Cancer is a group of diseases in which cells grow abnormally and uncontrollably. Transfection reagents are commonly used in cancer research to introduce foreign genetic material, such as plasmid DNA or RNA molecules, and allow researchers to investigate various aspects of cancer biology, such as gene expression studies, gene silencing, drug screening, and target validation. For instance, in 2021, according to the American Cancer Society, 1.8 million new cancer cases were diagnosed in 2020. Therefore, the rising number of cancer patients worldwide drives the growth of the transfection reagents and equipment market.
Key Industry Players
Major companies operating in the transfection reagents and equipment market report are Thermo Fisher Scientific Inc., Promega Corporation, Qiagen N.V., Bio-Rad Laboratories Inc., Maxcyte Inc., Lonza Group Ltd., Merck KGaA, Mirus Bio LLC, OriGene Technologies Inc., PromoCell GmbH, PerkinElmer Inc., Agilent Technologies Inc., Altogen Biosystems, Applied Biological Materials Inc., Bex Co. Ltd., Sartorius AG, Takara Bio Inc., Tecan Trading AG, Polyplus-transfection SA, Sigma-Aldrich Corporation, Hoffmann-La Roche Ltd., Transfection Technologies Inc., Viromer, ABM Inc., Bio-Techne Corporation, Biotium Inc., Cell Applications Inc., chemicell GmbH, Clontech Laboratories Inc., Genlantis, Inovio Pharmaceuticals Inc., Biontex Laboratories GmbH, Boca Scientific Inc., Jena Bioscience GmbH
The transfection reagents and equipment market report table of contents includes:
1. Executive Summary
2. Transfection Reagents And Equipment Market Characteristics
3. Transfection Reagents And Equipment Market Trends And Strategies
4. Transfection Reagents And Equipment Market – Macro Economic Scenario
5. Global Transfection Reagents And Equipment Market Size and Growth
.
.
.
31. Global Transfection Reagents And Equipment Market Competitive Benchmarking
32. Global Transfection Reagents And Equipment Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Transfection Reagents And Equipment Market
34. Transfection Reagents And Equipment Market Future Outlook and Potential Analysis
35. Appendix
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
